Unnamed Lilly "Mirror Fund" Acquires First Two Compounds
This article was originally published in The Pink Sheet Daily
Executive Summary
The acquisitions of two drug candidates - one from Lilly, one from a university - are the first in the pharma's latest scheme to share risk with VCs.